FENNEC PHARMACEUTICALS INC (FENC) Stock Earnings & Estimates
USA - NASDAQ:FENC - CA31447P1009 - Common Stock
8.7 USD
+0.3 (+3.57%)
8.7 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.54M | 21.252M 1,280.00% | 47.538M 123.69% | 47.623M 0.18% | 72.667M 52.59% | 86.385M 18.88% | 119.35M 38.16% | 171.5M 43.70% | 176.18M 2.73% | 181.38M 2.95% | 183.44M 1.14% | |
| EBITDA YoY % growth | N/A | N/A | N/A 216.67% | 17.646M 147.14% | 30.906M 75.14% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -22.59M -31.18% | -12.771M 43.47% | 2.568M 120.11% | 2.74M 6.70% | 20.835M 660.40% | 33.494M 60.76% | 57.624M 72.04% | 102.59M 78.03% | 101.55M -1.01% | 116.96M 15.17% | 127.06M 8.64% | |
| Operating Margin | -1,466.88% | -60.09% | 5.40% | 5.75% | 28.67% | 38.77% | 48.28% | 59.82% | 57.64% | 64.48% | 69.27% | |
| EPS YoY % growth | -0.90 -34.33% | -0.61 32.22% | 0.00 100.00% | 0.09 169,782,103,072,165,900.00% | 0.74 683.12% | 1.22 65.15% | 3.14 157.74% | 4.48 42.53% | 5.14 14.81% | 5.46 6.15% | 5.81 6.54% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.07 134.00% | 0.12 305.36% | 0.08 296.35% | 0.13 214.98% | 0.18 149.64% | 0.30 142.96% | 0.15 94.81% | 0.20 61.29% | 0.23 31.62% | 0.59 97.61% |
| Revenue Q2Q % growth | 13.7M 96.44% | 15.112M 90.69% | 14.798M 69.10% | 16.457M 70.50% | 17.939M 30.94% | 21.944M 45.21% | 18.033M 21.86% | 19.012M 15.53% | 20.155M 12.35% | 26.183M 19.32% |
| EBITDA Q2Q % growth | 2.448M 1,300.00% | 13.566M 2,560.00% | 3.264M 346.15% | 4.386M 377.78% | 5.61M 129.17% | 16.932M 24.81% | 5.61M 71.88% | 7.14M 62.79% | 8.262M 47.27% | 18.87M 11.45% |
| EBIT Q2Q % growth | 2.474M 147.58% | 3.848M 511.99% | 2.665M 429.83% | 3.295M 220.61% | 4.046M 63.54% | 9.776M 154.05% | 4.488M 68.41% | 6.018M 82.64% | 7.14M 76.47% | 17.748M 81.55% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.11 45.00% | -0.04 | -0.07 | -199.56% |
| Q1 2025 Q2Q % growth | -0.04 -108.51% | -0.09 | 0.05 | 55.84% |
| Q4 2024 Q2Q % growth | -0.06 40.00% | 0.17 | -0.23 | -135.44% |
| Q3 2024 Q2Q % growth | -0.21 -200.00% | -0.09 | -0.12 | -128.76% |
| Q2 2024 Q2Q % growth | -0.20 4.76% | -0.03 | -0.17 | -539.32% |
| Q1 2024 Q2Q % growth | 0.47 304.35% | 0.27 | 0.20 | 75.87% |
| Q4 2023 Q2Q % growth | -0.10 61.54% | -0.02 | -0.08 | -400.20% |
| Q3 2023 Q2Q % growth | -0.07 77.42% | -0.12 | 0.05 | 42.81% |
| Q2 2023 Q2Q % growth | -0.21 -10.53% | -0.16 | -0.05 | -31.55% |
| Q1 2023 Q2Q % growth | -0.23 -64.29% | -0.21 | -0.02 | -7.48% |
| Q4 2022 Q2Q % growth | -0.26 -44.44% | -0.27 | 0.01 | 3.75% |
| Q3 2022 Q2Q % growth | -0.31 -93.75% | -0.19 | -0.12 | -67.29% |
| Q2 2022 Q2Q % growth | -0.19 -26.67% | -0.14 | -0.05 | -36.30% |
| Q1 2022 Q2Q % growth | -0.14 22.22% | -0.14 | 0.00 | 1.96% |
| Q4 2021 Q2Q % growth | -0.18 -38.46% | 0.76 | -0.94 | -123.61% |
| Q3 2021 Q2Q % growth | -0.16 33.33% | -0.17 | 0.01 | 7.73% |
| Q2 2021 Q2Q % growth | -0.15 28.57% | -0.19 | 0.04 | 21.78% |
| Q1 2021 Q2Q % growth | -0.18 5.26% | -0.13 | -0.05 | -35.75% |
| Q4 2020 Q2Q % growth | -0.13 27.78% | -0.19 | 0.06 | 32.92% |
| Q3 2020 Q2Q % growth | -0.24 -166.67% | -0.19 | -0.05 | -23.84% |
| Q2 2020 Q2Q % growth | -0.21 12.50% | -0.18 | -0.03 | -16.53% |
| Q1 2020 Q2Q % growth | -0.19 -46.15% | -0.19 | 0.00 | 0.21% |
| Q4 2019 Q2Q % growth | -0.18 | -0.13 | -0.05 | -35.75% |
| Q3 2019 Q2Q % growth | -0.09 | -0.20 | 0.11 | 55.88% |
| Q2 2019 Q2Q % growth | -0.24 | -0.14 | -0.10 | -72.16% |
| Q1 2019 Q2Q % growth | -0.13 | -0.16 | 0.03 | 16.88% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 9.652M 32.91% | 9.707M | -55K | -0.57% |
| Q1 2025 Q2Q % growth | 8.751M -65.52% | 8.345M | 406K | 4.87% |
| Q4 2024 Q2Q % growth | 7.925M -18.59% | 17.051M | -9.126M | -53.52% |
| Q3 2024 Q2Q % growth | 6.974M 12.77% | 9.162M | -2.188M | -23.88% |
| Q2 2024 Q2Q % growth | 7.262M 118.41% | 11.269M | -4.007M | -35.56% |
| Q1 2024 Q2Q % growth | 25.377M 1,413.24% | 19.254M | 6.123M | 31.80% |
| Q4 2023 Q2Q % growth | 9.735M 532.14% | 8.843M | 892K | 10.09% |
| Q3 2023 Q2Q % growth | 6.184M | 5.443M | 741K | 13.61% |
| Q2 2023 Q2Q % growth | 3.325M | 3.81M | -485K | -12.73% |
| Q1 2023 Q2Q % growth | 1.677M | 1.884M | -207K | -10.99% |
| Q4 2022 Q2Q % growth | 1.54M | 759.727K | 780.273K | 102.70% |
| Q4 2021 Q2Q % growth | -100.00% | 34M | -34M | -100.00% |
| Q3 2020 Q2Q % growth | 484.5K | -484.5K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -33.96% | -28.57% | 0% | -37.57% |
| Revenue | 0.09% | 3.31% | -0.78% | -0.66% |